THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 119 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $558,000 | -28.9% | 38,459 | 0.0% | 0.01% | -37.5% |
| Q1 2021 | $785,000 | +8.6% | 38,459 | -5.4% | 0.01% | +14.3% |
| Q4 2020 | $723,000 | +20.3% | 40,660 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $601,000 | +22.7% | 40,660 | +74.2% | 0.01% | +16.7% |
| Q2 2020 | $490,000 | -9.1% | 23,344 | 0.0% | 0.01% | -25.0% |
| Q1 2020 | $539,000 | +3.5% | 23,344 | +16.1% | 0.01% | +33.3% |
| Q4 2019 | $521,000 | – | 20,106 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chescapmanager LLC | 1,134,718 | $23,160,000 | 2.47% |
| Baupost Group | 8,735,168 | $178,285,000 | 1.42% |
| Orbimed Advisors | 6,219,110 | $126,932,000 | 1.19% |
| CM Management, LLC | 50,000 | $1,021,000 | 0.76% |
| Tekla Capital Management LLC | 456,296 | $9,313,000 | 0.32% |
| Rock Springs Capital Management LP | 682,600 | $13,932,000 | 0.30% |
| Virtus ETF Advisers LLC | 32,871 | $671,000 | 0.28% |
| Cormorant Asset Management, LP | 550,000 | $11,226,000 | 0.25% |
| DAFNA Capital Management LLC | 41,165 | $840,000 | 0.20% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 484,206 | $9,883,000 | 0.18% |